Loss of function mutations of BCOR in classical Hodgkin lymphoma.
Maciej GiefingMicah D GearhartMarkus SchneiderBirte OverbeckWolfram KlapperSylvia HartmannAdam UstaszewskiMarc A WenigerLaura WiehleMartin-Leo HansmannAri MelnickWendy BéguelinChrister SundströmRalf KüppersVivian J BardwellReiner SiebertPublished in: Leukemia & lymphoma (2021)
BCOR is a component of a variant Polycomb repressive complex 1 (PRC1.1). PRC1 and PRC2 complexes together constitute a major gene regulatory system critical for appropriate cellular differentiation. The gene is upregulated in germinal center (GC) B cells and mutated in a number of hematologic malignancies. We report BCOR inactivating alterations in 4/7 classic Hodgkin lymphoma (cHL) cell lines, subclonal somatic mutations in Hodgkin and Reed-Sternberg (HRS) cells of 4/10 cHL cases, and deletions in HRS cells of 7/17 primary cHL cases. In mice, conditional loss of Bcor driven by AID-Cre in GC B cells resulted in gene expression changes of 46 genes (>2-fold) including upregulated Lef1 that encodes a transcription factor responsible for establishing T-cell identity and Il9r (interleukin-9 receptor), an important member of the cytokine network in cHL. Our findings suggest a role for BCOR loss in cHL pathogenesis and GC-B cell homeostasis.
Keyphrases
- hodgkin lymphoma
- induced apoptosis
- clear cell
- gene expression
- transcription factor
- cell cycle arrest
- genome wide
- genome wide identification
- endoplasmic reticulum stress
- copy number
- dna methylation
- gas chromatography
- signaling pathway
- oxidative stress
- type diabetes
- high resolution
- high fat diet induced
- insulin resistance
- simultaneous determination